当前位置:首页 - 行情中心 - 百诚医药(301096) - 财务分析

百诚医药

(301096)

  

流通市值:53.02亿  总市值:69.70亿
流通股本:8309.00万   总股本:1.09亿

百诚医药(301096)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润0.13亿元,每股收益0.12元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益250177.74万元,未分配利润28129.24万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产380238.19万元,负债130060.45万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入160,457,682.24677,987,094.68509,883,681.59332,353,112.78
营业总成本151,266,524.68748,339,939.83508,846,004.57336,557,099.34
其他经营收益
营业利润12,196,917.65-89,034,649.177,650,161.613,685,713.16
利润总额12,247,472.65-91,138,964.387,965,059.063,900,486.09
净利润12,812,458.42-90,395,530.086,124,209.963,098,160.54
每股收益
其他综合收益11,144-40,484.38-42,606.52-30,111.11
综合收益总额12,823,602.42-90,436,014.466,081,603.443,068,049.43
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计1,698,414,001.241,552,083,379.641,818,269,330.281,732,648,797.08
非流动资产:
非流动资产合计2,103,967,906.052,134,184,239.542,128,658,111.862,142,291,514.81
资产总计3,802,381,907.293,686,267,619.183,946,927,442.143,874,940,311.89
流动负债:
流动负债合计906,457,407.83919,912,108.281,030,000,641.09951,870,447
非流动负债:
非流动负债合计394,147,127.22277,401,741.08331,455,413.33340,612,031.18
负债合计1,300,604,535.051,197,313,849.361,361,456,054.421,292,482,478.18
所有者权益(或股东权益):
归属于母公司股东权益合计2,501,777,372.242,488,953,769.822,585,471,387.722,582,457,833.71
股东权益合计2,501,777,372.242,488,953,769.822,585,471,387.722,582,457,833.71
负债和股东权益合计3,802,381,907.293,686,267,619.183,946,927,442.143,874,940,311.89
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计118,415,232.6434,556,414.02253,832,979.49211,529,707.21
经营活动现金流出小计125,266,312.66589,201,103.91433,618,596.71325,948,946.26
经营活动产生的现金流量净额-6,851,080.06-154,644,689.89-179,785,617.22-114,419,239.05
投资活动产生的现金流量:
投资活动现金流入小计31,706,160.43418,505,415.52308,533,773.48238,640,556.86
投资活动现金流出小计50,573,746.85539,310,775.12497,016,464.8374,813,468.47
投资活动产生的现金流量净额-18,867,586.42-120,805,359.6-188,482,691.32-136,172,911.61
筹资活动产生的现金流量:
筹资活动现金流入小计290,411,113.11,061,282,342.62816,782,342.6510,000,000
筹资活动现金流出小计158,195,038.48921,438,959.66507,875,522.38276,094,193.78
筹资活动产生的现金流量净额132,216,074.62139,843,382.96308,906,820.22233,905,806.22
汇率变动对现金及现金等价物的影响-2,550.9-78,180.21312,756.01326,514.9
现金及现金等价物净增加额106,494,857.24-135,684,846.74-59,048,732.31-16,359,829.54
期末现金及现金等价物余额386,971,356.56280,476,499.32357,112,613.75399,801,516.52
补充资料:
现金及现金等价物的净增加额--135,684,846.74--16,359,829.54
最新报告期:2026-04-29
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
东吴证券苏丰,朱国广,邹行健1.101.862.172026-04-29
东吴证券苏丰,朱国广,邹行健1.101.86--2026-03-12
TOP↑